Kriterien der alkohol- und substanzbezogenen Störungen im ICD-11

Ulrich W. Preuss; Eva Hoch; Wong Jessica Wei Mooi

doi:10.1055/a-1467-0986

Nervenheilkunde, Table of Contents

Nervenheilkunde 2021; 40(08): 598-608
DOI: 10.1055/a-1467-0986

Schwerpunkt

Kriterien der alkohol- und substanzbezogenen Störungen im ICD-11

Was ändert sich?Criteria of alcohol and substance use disorders in ICD-11What changes?

Ulrich W. Preuss∗

²Vitos Klinik Psychiatrie und Psychotherapie, Herborn und Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Martin-Luther-Universität, Halle-Wittenberg

,

Eva Hoch∗

³Klinik und Poliklinik für Psychiatrie und Psychotherapie, Klinikum Innenstadt, Ludwig-Maximilians-Universität, München

⁴Klinische Psychologie und Psychotherapie, Abteilung für Psychologie, Ludwig-Maximilians-Universität, München

,

Wong Jessica Wei Mooi∗

¹Klinik am Homberg, Bad Wildungen

› Author Affiliations

Abstract

ZUSAMMENFASSUNG

Die ICD-10-Kriterien für alkohol- und substanzbezogene Abhängigkeit und schädlichen Gebrauch sind seit 1991 gültig. Ziele des Reviews sind, die Änderungen und Erweiterungen der Diagnosen zu substanzbezogenen Störungen im ICD-11 (International Classification of Diseases Version 11) am Beispiel der Alkoholkonsumstörungen zu erläutern sowie Gemeinsamkeiten und Unterschiede zum DSM-5 (Diagnostic and Statistical Manual 5), das vor allem in den USA gebräuchlich ist, darzustellen. Darüber hinaus folgt eine kritische Betrachtung des Übertrages von ICD-10- auf -11-Diagnosen sowie Limitationen und Kritik an der Konzeption des ICD-11 und hinsichtlich der Verwendbarkeit in der Praxis.

Abstract

The current ICD-10 criteria for alcohol and substance-related dependence and harmful use have been in effect since 1991. The aims of this review are to explain the changes and extensions of the diagnoses of substance-related disorders in ICD-11 (International Classification of Diseases Version 11) using the example of alcohol use disorders: S similarities and differences to DSM-5 (Diagnostic and Statistical Manual 5) are presented. DSM is mainly used in the USA. In addition, a critical re-appraisal of the transfer of ICD-10 to -11 diagnoses and limitations and criticism of the conception of ICD-11 and regarding usability in practice are included.

Schlüsselwörter

ICD-10 - ICD-11 - DSM-IV - DSM-5 - alkoholbezogene Störungen

Key words

ICD-10 - ICD-11 - DSM-IV - DSM-5 - alcohol use disorder

Full Text

References

Literatur
1 World Health Organization. International Classification of Diseases. WHO, Geneva: World Health Organization; 1991
2 Li TK, Hewitt BG, Grant BF. The alcohol dependence syndrome, 30 years later: a commentary. The 2006 H. David Archibald lecture. Addiction 2007; 102: 1522-1530
3 Edwards G. The Alcohol Dependence Syndrome: a concept as stimulus to enquiry. Br J Addict 1986; 81: 171-183
4 Saunders JB, Degenhardt L, Reed GM et al. Alcohol Use Disorders in ICD-11: Past, Present, and Future. Alcohol Clin Exp Res 2019; 43: 1617-1631
5 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Arlington, VA: American Psychiatric Association; 2013
6 Karriker-Jaffe KJ, Room R, Giesbrecht N et al.. Alcohol’s harm to others: opportunities and challenges in a public health framework. J Stud Alcohol Drugs 2018; 79: 239-243
7 Martin CS, Sher KJ. Drinkers’ harm to others: a commentary. J Stud Alcohol Drugs 2018; 79: 244-245
8 Tai YF, Saunders JB, Celermajer DS. Collateral damage from alcohol abuse: the enormous costs to Australia. Med J Aust 1998; 168: 6-7
9 Mann K, Batra A, Fauth-Bühler M et al. Guideline Group German Guidelines on Screening, Diagnosis and Treatment of Alcohol Use Disorders. Eur Addict Res 2017; 23: 45-60
10 Meier P, Seitz HK. Age, alcohol metabolism and liver disease. Curr Opin Clin Nutr Metab Care 2008; 11: 21-26
11 GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet; 2018. 392. 1015-1035
12 Rehm J, Baliunas D, Borges GLG et al.. The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction 2010; 105: 817-843
13 Rehm J, Taylor B, Mohapatra S et al.. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev 2010; 29: 437-445
14 Martinotti G, Santacroce R, Papanti D et al.. Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset. CNS Neurol Disord Drug Targets 2017; 16: 567-575
15 Bond J, Ye Y, Cherpitel CJ et al.. Scaling properties of the combined ICD-10 dependence and harms criteria and comparisons with DSM-5 alcohol use disorder criteria among patients in the emergency department. J Stud Alcohol Drugs 2012; 73: 328-336
16 Lago L, Bruno R, Degenhardt L. Concordance of ICD-11 and DSM- 5 definitions of alcohol and cannabis use disorders: a population survey. Lancet Psychiatry 2016; 3: 673-684
17 Degenhardt L, Bharat C, Bruno R et al on behalf of the WHO World Mental Health Survey Collaborators. Concordance between the diagnostic guidelines for alcohol and cannabis use disorders in the draft ICD-11 and other classification systems: analysis of data from the WHO’s World Mental Health Surveys. Addiction 2019; 114: 534-552
18 Rehm J, Heilig M, Gual A. ICD-11 for Alcohol Use Disorders: Not a Convincing Answer to the Challenges. Alcohol Clin Exp Res 2019; 43: 2296-2300
19 Kwako LE, Momenan R, Litten RZ et al.. Addictions neuro-clinical assessment: a neuroscience-based framework for addictive disorders. Biol Psychiatry 2016; 80: 179-189
20 Lachenmeier DW, Gmel G, Rehm J. Unrecorded alcohol consumption, In: Boyle P et al. (eds.) Alcohol: Science, Policy, and Public Health. Oxford; University Press Oxford UK: 2013: 132-142
21 Martin CS, Langenbucher JW, Chung T et al.. Truth or consequences in the diagnosis of substance use disorders. Addiction 2014; 109: 1773-1778
22 Rehm J, Room R. The cultural aspect: how to measure and interpret epidemiological data on alcohol use disorders across cultures. Nordic Stud Alcohol Drugs 2017; 34: 330-341
23 Carvalho AF, Heilig M, Perez A et al.. Alcohol use disorders. Lancet 2019; 394: 781-792
24 Heilig M, Epstein DH, Nader MA et al.. Time to connect: bringing social context into addiction neuroscience. Nat Rev Neurosci 2016; 17: 592-599
25 Bush K, Kivlahan DR, McDonell MB et al.. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med 1998; 158: 1789-1795
26 Walters RK, Polimanti R, Johnson EC et al.. Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders. Nat Neurosci 2018; 21: 1656-1669
27 Rehm J, Anderson P, Gual A et al.. The tangible common denominator of substance use disorders: a reply to commentaries to Rehm et al. (2013). Alcohol Alcohol 2014; 49: 118-122
28 Rehm J, Anderson P, Barry J et al.. Prevalence of and potential influencing factors for alcohol dependence in Europe. Eur Addict Res 2015; 21: 6-18
29 Manthey J, Shield K, Rylett M et al.. Alcohol exposure between 1990 and 2017 and forecasts until 2030: a global modelling study. Lancet 2019; 393: 2493-2502
30 Room R, Rehm J. Commentary on Degenhardt et al. Harm to others matters in substance use disorders, and so does discordance between the diagnostic systems. Addiction 2019; 114: 553-554
31 Rehm J, Anderson P, Manthey J et al.. Alcohol use disorders in primary health care: What do we know and where do we go?. Alcohol Alcohol 2016; 51: 422-427
32 Schomerus G, Matschinger H, Angermeyer MC. Continuum beliefs and stigmatizing attitudes towards persons with schizophrenia, depression and alcohol dependence. Psychiatry Res 2013; 209: 665-669
33 Rehm J, Gmel GE, Gmel G et al.. The relationship between different dimensions of alcohol use and the burden of disease – an update. Addiction 2017; 112: 968-1001
34 Roerecke M, Tobe SW, Kaczorowski J et al.. Sex-specific associations between alcohol consumption and incidence of hypertension: a systematic review and meta-analysis of cohort studies. J Am Heart Assoc 2018; 7: pii-e008202